BNET Industries

Market Cap:$19.9M
Last Fiscal Year Sales:$47.0M
  • Public
  • US
Dow Jones Description

Leveraging its biotechnology heritage, Nutrition 21 is pioneering an effort to use patented technology, pharmaceutical research and strategic marketing and distribution partnerships to build its position in therapeutic markets. The Company is targeting specific disease states and age related health care concerns through its Chromax , Diachrome , Iceland Health , and Selenomax brands. The disease states include obesity/pre-diabetes, metabolic syndrome, diabetes, cardiovascular health, arthritis, mood disorders, and immune system dysfunction (HIV). Nutrition 21 relies on large scale double blind-placebo controlled clinical trials as a key element of its product development and marketing strategy. The Company's objective is to translate its scientific findings into trusted brands recognized for their measurable contribution to improving health and reducing cost of care. The Company earns the trust of consumers with endorsements from healthcare professionals and by getting our products adopted as a standard therapy recommended by doctors and health care professionals. Different from most biotechnology or pharmaceutical companies, the Company is focused on developing products that are marketed under the Dietary Supplement Health and Education Act (DSHEA) regulatory pathway. The Food and Drug Administration's (FDA) regulations for the supplement category enable companies to bring products to market in less time and with less cost than is required for FDA drug approval...

President, Chief Executive OfficerMichael A. Zeher
Number of Employees 20
Contact Information

4 Manhattanville Rd

Purchase, New York 10577-2139

nutrition21.com

1 914 701 4500

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association...

    3/30/09 - Board Member - Entering - View Story

News & Analysis

nutrition 21 inc. - All News and Analysis

Additional Resources

  • New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings

    - 2009-05-14

    U.S.D.A. Animal Studies: Chromium Picolinate and Chromium Histidinate Down-regulate Gene in Brain that Precedes Alzheimer's Disease Additional Studies Continue to Demonstrate Safety and Efficacy of Nutrition 21's Chromax Chromium Picolinate PURCHASE, N.Y., May 14 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. , the developer and marketer of...

  • Nutrition 21 Announces Financial Results for Q3 Fiscal 2009

    - 2009-05-12

    Fourth Consecutive Positive EBITDA Quarter in Q3 2009 PURCHASE, N.Y., May 12 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. , the developer and marketer of nutritional supplements under the Iceland HealthR, ChromaxR and Diabetes EssentialsR brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and...

  • Nutrition 21 to Report Third Quarter Fiscal Year 2009 Financial Results on Tuesday, May 12, 2009

    - 2009-05-05

    PURCHASE, N.Y., May 5 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. , a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, will report financial results - prior to the opening of the market - on Tuesday,...

  • Nutrition 21 Redeems Series I Convertible Preferred Shares

    - 2009-04-01

    PURCHASE, N.Y., April 1 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. , a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, announced today that on March 31, 2009 it redeemed all of its Series I outstanding...

  • Nutrition 21

    - 2009-01-19

    PURCHASE, N.Y. -- Nutrition 21 is a nutritional bioscience company and the marketer of supplements based on omega-3 fish oil and chromium picolinate, with health benefits substantiated by clinical research. Nutrition 21's portfolio of health and wellness brands include Iceland Health and Diabetes Essentials. The Iceland Health brand...

  • Advana Science

    - 2009-01-01

    Advana Science, Kirkland, WA, has appointed Rick Kaiser vice president of sales. He will be responsible for executing Advana's commercialization model of its new biotechnology discoveries in beta amyloid plaque reduction. Mr. Kaiser has more than 30 years of sales experience in the pharmaceutical and nutraceutical industries, working with companies...

  • Nutrition 21

    - 2008-12-01

    Nutrition 21, Purchase, NY, has appointed Pam McWilliams vice president and general manager of the company's Direct Response Group. Her responsibilities include new business development, sales strategy, vendor operations and management of the Direct Response Group. She previously served as a direct marketing consultant for Propeller Consulting...

  • Nutrition 21 Appoints VP and GM of Direct Response.

    - 2008-10-30

    TRAVEL AND LEISURE CLOSE-UP-30 October 2008-Nutrition 21 Appoints VP and GM of Direct ResponseC2008 - CloseUpMedia - newsdesk@closeupmedia.com Nutrition 21 announced the appointment of Pam McWilliams as vice president and general manager of the company's Direct Response Group. ...

Decision Makers

Name (plus bio) Position
Michael A. Zeher President, Chief Executive Officer
Michael Fink Co-CEO
Alan J. Kirschbaum CFO, Vice President, Finance & Treasurer
Andrew Wertheim COO
Gerard Butler Co-Coo
Paul Serini Executive Vice President, Health
Benjamin T. Sporn General Counsel, Senior Vice President & Secretary
Dean DiMaria Senior Vice President
James Komorowski Vice President, Technical Services
Mary Swatek Hudson Vice President, Market Development
William J Levi Vice President of Operations and Business Development
John L. Cassis Partner
Jeffrey Geohas Director, Research
Manley Finch Assoc Director, Research
Walter Glinsmann Associate Director
P. George Benson Director
Warren D Cooper Director

Board of Directors

Name (plus bio) Position
John H. Gutfreund Chairman
Audrey T. Cross Board of Directors
Marvin Moser Board of Directors
Paul Intlekofer Board of Directors
Peter C. Mann Board of Directors
Organization Position Status
Nutrition 21, Inc. President, Chief Executive Officer Current
Chromax President & CEO Current
Chromax Board of Directors Current
Nutrition 21, Inc. Board of Directors Current
Matrixx Initiatives, Inc. Board of Directors Current
International Ltd Chief Executive Officer Former
Nutritional Laboratories International Chief Executive Officer Former
Nutritional Laboratories International President Former
Pharmaceutical Formulations, Inc. President Former
International Ltd President Former
Pharmaceutical Formulations, Inc. Chief Operating Officer Former
Old Dominion University BS Degree In Business Administration Former
Organization Position Status
Nutrition 21, Inc. Co-CEO Current

Alan J. Kirschbaum, a Certified Public Accountant, was elected Chief Financial Officer on May 26, 2006. From July 2002 to April 2006, he was Vice President, Finance and Treasury, and Principal Accounting Officer. From December 1998 to June 2002 he served the Company as Controller. From 1996 to 1998, Mr. Kirschbaum was Vice President and Controller of AMS Asset Management Services. From 1984 to 1996, he held a series of increasingly responsible financial positions with Ascom Timeplex, Inc. He holds a BS from Pennsylvania State University, an MBA from Pace University.

Organization Position Status
Nutrition 21, Inc. CFO, Vice President, Finance & Treasurer Current
Chromax Certified Public Accountant Current
Nutrition 21, Inc. Certified Public Accountant Current
Nutrition 21, Inc. Controller Former
Pace University Mba Former
The Pennsylvania State University Bs Former
Organization Position Status
Nutrition 21, Inc. COO Current
Organization Position Status
Nutrition 21, Inc. Co-Coo Current
Organization Position Status
Nutrition 21, Inc. Executive Vice President, Health Current
Organization Position Status
Nutrition 21, Inc. General Counsel, Senior Vice President & Secretary Current
Organization Position Status
Nutrition 21, Inc. Senior Vice President Current
Nutrition 21, Inc. Vice President of Sales and Marketing Current
Chromax Vice President of Sales and Marketing Current
Natural Health Products Vice President of Sales Former
Natural Health Products General Manager Former
Boehringer Ingelheim Corporation Former
Church & Dwight Co., Inc. Former
Western Michigan University Bachelor of Science Degree In Marketing Former
Organization Position Status
Chromax Vice President, Technical Services and Scientific Affairs Current
Nutrition 21, Inc. Vice President, Technical Services Current
Fda.Com Former
Long Island University M.S. in medical biology Former
The State University of New York BA degree in biology Former
Organization Position Status
Nutrition 21, Inc. Vice President, Market Development Current

William J. Levi has served as Vice President of Operations and Business Development since May, 2006. Mr. Levi joined Nutrition 21 as Business Director, Ingredients in October, 2001. Mr. Levi has over 25 years of general management, and senior sales and marketing experience in the food and nutraceutical ingredient industries for North American and International markets. Prior to joining Nutrition 21, Mr. Levi held various senior management positions most recently with ACH Foods headquartered in Memphis, Tennessee where he served as General Manager of the Humko Oils and Specialty Ingredients divisions with responsibility for operations, sales, marketing and technical service functions. Prior to joining ACH in 1996, he served as Director of Sales and Marketing for Abitec Corporation. Mr. Levi began his food industry career in 1977 with Durkee Foods. Mr. Levi holds a BA from the University of Dayton.

Organization Position Status
Nutrition 21, Inc. Vice President of Operations and Business Development Current
Ingredients Business Director Former
Abitec Corporation Director of Sales and Marketing Former
University of Dayton BA Former
Organization Position Status
Cross Atlantic Partners Managing Partner Current
Chromax Partner Current
Nutrition 21, Inc. Partner Current
Accredo Health, Incorporated Current
Eximias Pharmaceutical Corporation Chairman Current
Galt Associates, Inc. Director Current
Nutrition 21, Inc. Board of Directors Current
Preferred Global Health Director Current
Medivance, Inc. Director Current
Medco Health Solutions, Inc. Board of Directors Current
Chromax Board of Directors Current
Dlife Board of Directors Current
Medco Health Solutions, Inc. Committee Member Current
Johnson & Johnson Development Corp. Founder Former
J & J Development, Inc. Founder Former
Johnson & Johnson Manager Former
Acquisitions Ltd. Manager Former
Medco Health Solutions, Inc. Chair Person, Compensation Committee Former
Medivance, Inc. Chairman Former
Galt Associates, Inc. Chairman Former
Nutrition 21, Inc. Chairman Former
ILEX Oncology, Inc. Chairman Former
Impath, Inc. Board Member Former
Harvard Business School Mba '72 Former
Harvard University Ba '70 Former
Organization Position Status
Nutrition 21, Inc. Director, Research Current
Nutrition 21, Inc. Director, Research Former
Organization Position Status
Nutrition 21, Inc. Assoc Director, Research Current
Nutrition 21, Inc. Associate Director, Research Former
Organization Position Status
Nutrition 21, Inc. Associate Director Current

John H. Gutfreund , age 78, is Senior Advisor of Collins Stewart LLC, an investment partnership for high-growth technology companies, a position he has held since January 2002. Since 1993, Mr. Gutfreund has also been the President of Gutfreund & Co. Inc., a financial management consulting firm. Formerly, Mr. Gutfreund was with Salomon Brothers from 1953-1991, most recently as its Chairman. Mr. Gutfreund is a director of AXES LLC, Evercel, Inc., and Montefiore Medical Center. He is chairman of the Board for Nutrition 21, Inc. He is an advisor to The Universal Bond Fund and member of The Brookings Institution, Council Advisory Committee in New York; member, Council on Foreign Relations; Lifetime Member, Board of Trustees, New York Public Library; Honorary Trustee, Oberlin (Ohio) College; and Chairman Emeritus and Member of the Board of Trustees, Aperture Foundation. He has served as a director of the Company since 1997. John C. Hassan , age 65, has been a consultant to BSC Ventures, a holding company in the printing and converting industry, since November 2006. Prior to that, he had been the President and CEO of Champion Printing, Inc., a direct mail printing company, for more than 15 years. Previously, he was Vice President Marketing of the Drackett Company, a division of Bristol-Myers Squibb. He currently serves on the boards of the Ohio Graphics Arts Health Fund and the Madeira/Indian Hill Fire Company. He has served as a director of the Company since 1996.

Organization Position Status
Collins Stewart Limited Senior Advisor Current
Xanalys Corporation Current
Nutrition 21, Inc. Chairman Current
CompuDyne Corporation Chair Current
Lasik Plus Vision Center Board of Directors Current
LCA-Vision Inc. Board of Directors Current
The Brookings Institution Board of Directors Current
Stern & Co Board of Directors Current
Nutrition 21, Inc. Board of Directors Current
Maxicare Health Plans, Inc. Director Current
Chromax Board of Directors Current
Axes LLC Director Current
AccuWeather, Inc. Director Current
Maxicare Board of Directors Current
Evercel, Inc. Director Current
The Brookings Institution Member Current
C.E. Unterberg, Towbin Member Current
Champion Printing, Inc. CEO Former
Salomon Brothers Chief Executive Officer Former
Champion Printing, Inc. President Former
C.E. Unterberg, Towbin Managing Director Former
C.E. Unterberg, Towbin Executive Committee member Former
The Board, Inc. Chairman Former
LCA-Vision Inc. Director Former
Oberlin College BA Former

Audrey T. Cross, PhD, was elected a Director of the Company in January 1995. Dr. Cross has been Associate Clinical Professor at the Institute of Human Nutrition at the School of Public Health of Columbia University since 1988. She also works as a consultant in the areas of nutrition and health policy. She has served as a special assistant to the United States Secretary of Agriculture as Coordinator for Human Nutrition Policy and has worked with both the United States Senate and the California State Senate on nutrition policy matters. Dr. Cross received a BS in dietetics, a Master of Public Health in nutrition and a PhD from the University of California at Berkeley, and a JD from the Hastings College of Law at the University of California at San Francisco.

Organization Position Status
Nutrition 21, Inc. Board of Directors Current
University of California, San Francisco Former
Hastings College of the Law Jd Former
University of California, Berkeley PhD Former
University of California, Berkeley Master of Public Health In Nutrition Former
Hastings College of the Law Master of Public Health In Nutrition Former
Hastings College of the Law BS In Dietetics Former
University of California, Berkeley BS In Dietetics Former
Organization Position Status
Nutrition 21, Inc. Board of Directors Current
Cornell University BA Former
Organization Position Status
National Bank Of South Carolina President, College of Charleston Current
College of Charleston President Current
Nutrition 21, Inc. Director Current
Jekyll Island Board of Directors Current
National Bank Of South Carolina Board of Directors Current
Crawford & Company Board of Directors Current
Claims Management Services Ltd Senior Vice President Former
Carlson School of Management Professor of Decision Sciences Former
The University of Georgia Dean Former
Bell Telephone Laboratories Former
The University of Georgia Chairman of Board Former
University of Florida PhD In Business Former
Bucknell University Bs In Mathematics Former
Organization Position Status
Nutrition 21, Inc. Board of Directors Current
Nutrition 21, Inc. President & CEO Former
Nutrition 21, Inc. CFO & Senior Vice President Former
University of Maryland MBA Former
Organization Position Status
Prestige Brands, Inc. President, Chief Executive Officer and Manager Current
Prestige Brands Holdings, Inc. Chairman, Interim President & CEO Current
Westhill Partners, Ltd. Operating Partner Current
GTCR Golder Rauner, LLC Current
Nutrition 21, Inc. Board of Directors Current
Chromax Board of Directors Current
Prestige Brands, Inc. Board of Directors Current
Clear Eyes Board of Directors Current
The Spic & Span Company President Former
Medtech, Inc. President Former
Brown University BA Former
Organization Position Status
Prism Pharmaceuticals CEO Current
Prism Pharmaceuticals President Current
Nutrition 21, Inc. Director Current
Chromax Director Current
AstraZeneca Pharmaceuticals LP Business Unit Leader Former
Professional Resources & Information Systems Management Inc Former

Executive News

  • LCA-Vision Reports on Annual Meeting of Stockholders

    PR Newswire - 6/02/09 - View Story

advertisement
     NXXI $0.26 -0.02 (-6.42% )
Average Volume 248,344
Shares Outstanding 71.23M
Market Cap 18.2M
Year High 0.58
Year Low 0.07
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
Glass Door

Pharma Industry Companies

Company Employer Rating
Pfizer 3.0
advertisement